Request Deal Involvement

Vida Ventures, Cormorant Asset Management and Hillhouse Investment led a $165m Series A funding round in Third Arc Bio.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Cooley

legal advisors

Cooley

Gibson Dunn & Crutcher

legal advisors

Gibson Dunn & Crutcher

or

Principals

THIRD ARC BIO

target

THIRD ARC BIO

VIDA VENTURES

bidder

VIDA VENTURES

CORMORANT ASSET MANAGEMENT

bidder

CORMORANT ASSET MANAGEMENT

HILLHOUSE CAPITAL GROUP

bidder

HILLHOUSE CAPITAL GROUP

OMEGA FUNDS

bidder

OMEGA FUNDS

GOLDMAN SACHS ALTERNATIVES

bidder

GOLDMAN SACHS ALTERNATIVES

BVF PARTNERS

bidder

BVF PARTNERS

JANUS HENDERSON INVESTORS

bidder

JANUS HENDERSON INVESTORS

ABRDN INC

bidder

ABRDN INC

MARSHALL WACE

bidder

MARSHALL WACE

FORESITE CAPITAL MANAGEMENT LLC

bidder

FORESITE CAPITAL MANAGEMENT LLC

LOGOS CAPITAL

bidder

LOGOS CAPITAL

ABBVIE BIOTECH VENTURES

bidder

ABBVIE BIOTECH VENTURES

FREEPOINT CAPITAL GROUP

bidder

FREEPOINT CAPITAL GROUP

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Vida Ventures, Cormorant Asset Management and Hillhouse Investment led a $165m Series A funding round in Third Arc Bio.